ClinConnect ClinConnect Logo
Search / Trial NCT06584695

Analgesic Efficacy of External Oblique Intercostal Block vs Subcostal Transversus Abdominis Plane Block in Open Surgical Nephrectomy

Launched by CAIRO UNIVERSITY · Sep 2, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for cancer patients undergoing open nephrectomy, which is a surgery to remove a kidney. The researchers want to find out which method works better: one that targets a specific area in the abdomen using ultrasound guidance (the external oblique intercostal block) or another that focuses on a different area of the abdomen (the subcostal transversus abdominis plane block). The goal is to see how effective each technique is in managing pain during and after the surgery.

To participate in this trial, patients need to be between 18 and 65 years old and have a cancer diagnosis that requires them to have an open nephrectomy. They should be in good overall health according to the American Society of Anesthesiologists (ASA) classification, which assesses a patient's physical status. However, patients with certain conditions, such as severe obesity, cognitive disorders, or those who have allergies to the medications used, won't be eligible. Participants can expect to receive one of the two pain relief methods during their surgery and will be monitored for their pain levels afterward. The trial is currently recruiting participants to join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age (18-65) year.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) class II and III.
  • Cancer patients candidate for open nephrectomy .
  • Exclusion Criteria:
  • Patient refusal.
  • Skin lesions or infection at the site of proposed needle insertion.
  • Cognitive disorders.
  • History of psychiatric disorders or drug abuse.
  • Patients allergic to medication used.
  • ASA class IV.
  • Coagulopathy.
  • Body mass index (BMI) more than 35.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported